Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
SEC ownership of Rezolute, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001509261.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Symbol
- RZLT on Nasdaq
- SEC evidence covered
- 13D/G and 13F
- Largest SEC-reported holder
- RA CAPITAL MANAGEMENT, L.P.
- Latest 13D/G holder
- RA CAPITAL MANAGEMENT, L.P.
- Latest parsed evidence date
- 31 Mar 2026
- CIK
- 0001509261
- Location
- Redwood City, CA
Ownership snapshot
2 signals
Issuer
2 identity fields
Ownership snapshot
Top shareholders of Rezolute, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: RA CAPITAL MANAGEMENT, L.P.
Showing 1-8 of 50 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 9.9%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
9.9%
Opaleye Management Inc.
6.6%
BANK OF AMERICA CORP /DE/
6.5%
BlackRock, Inc.
5.4%
BALYASNY ASSET MANAGEMENT L.P.
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
RA Capital Healthcare Fund, L.P. · Company
|
9.9%
|
$146,288,898
15,302,186 shares
|
$0 | 11 Dec 2025 |
| Opaleye Management Inc. |
13D/G
13F
Company
|
6.6%
|
$22,932,000
6,300,000 shares
|
+$5,049,044 | 31 Mar 2026 |
| BANK OF AMERICA CORP /DE/ |
13D/G
13F
Company
|
6.5%
|
$14,372,832
6,064,486 shares
|
$0 | 31 Dec 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5.4%
|
$45,886,185
4,881,509 shares
|
$0 | 30 Sep 2025 |
| BALYASNY ASSET MANAGEMENT L.P. |
13D/G
13F
Company
|
5.3%
|
$18,376,252
5,048,421 shares
|
$0 | 31 Mar 2026 |
| Nantahala Capital Management, LLC |
13D/G
|
4.9%
|
$11,317,609
2,857,982 shares
|
-$8,350,591 | 31 Dec 2024 |
| FMR LLC |
13D/G
13F
Company
|
2.5%
|
$5,379,582
2,305,568 shares
|
-$24,514,368 | 31 Dec 2025 |
| FEDERATED HERMES, INC. |
13F
Company
|
14%
|
$39,621,510
12,990,659 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$4,330,057.
Buys
$4,330,057
Insiders: 7
Sells
$0
Insiders: 0
Net
+$4,330,057
Shares: +1,384,644
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 1,384,644
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 10,000 | 0 | $28,500 | $0 | +$28,500 |
| 3-6 | 133,299 | 0 | $260,372 | $0 | +$260,372 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 1,241,345 | 0 | $4,041,185 | $0 | +$4,041,185 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to Rezolute, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Genexine Inc.
Net 12M change
+$4,330,057
Latest report
30 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Genexine Inc. | 10%+ Owner | $173,462,643 | Mixed | 26 Apr 2019 | ||
| Young-Jin Kim | Director | $78,981,947 | +$3,999,999 | +5.3% | Mixed | 19 Nov 2025 |
| HANDOK, INC. | Director, 10%+ Owner | $10,051,937 | Mixed | 15 Oct 2021 | ||
| Nevan C. Elam | CEO, Director | $2,049,093 | +$50,880 | +2.5% | Mixed | 02 Mar 2026 |
| Daron Evans | Cfo | $1,410,136 | +$181,494 | +15% | Mixed | 30 Mar 2026 |
| Brian Kenneth Roberts | Chief Medical Officer | $1,043,459 | +$58,539 | +5.9% | Mixed | 02 Mar 2026 |
| Gil M. Labrucherie | Director | $1,002,371 | Mixed | 19 Nov 2025 | ||
| Nerissa Kreher | Director | $538,313 | +$9,997 | +1.9% | Mixed | 19 Nov 2025 |
| Philippe Fauchet | Director | $510,045 | Mixed | 19 Nov 2025 | ||
| Sunil Patilal Karnawat | Chief Commercial Officer | $209,091 | +$19,599 | +10% | Mixed | 15 Dec 2025 |
| Wladimir Hogenhuis | Director | $202,250 | +$9,549 | +5% | Filing P/S | 16 Dec 2025 |
| Erik Harris | Director | $192,990 | Mixed | 19 Nov 2025 |
Recent insider transactions for Rezolute, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Daron Evans | RZLT | Common Shares | Purchase | 2.47% | $28,500 | $2.85 | 10,000 | 414,462 | 30 Mar 2026 | Direct |
| Brian Kenneth Roberts | RZLT | Common Shares | Tax liability | -3.71% | -11,439 | 296,913 | 02 Mar 2026 | Direct | ||
| Daron Evans | RZLT | Common Shares | Tax liability | -2.75% | -11,438 | 404,462 | 02 Mar 2026 | Direct | ||
| Nevan C. Elam | RZLT | Common Shares | Tax liability | -4.31% | -27,618 | 613,501 | 02 Mar 2026 | Direct | ||
| Wladimir Hogenhuis | RZLT | Common Shares | Purchase | 4.96% | $9,548 | $1.69 | 5,650 | 119,675 | 16 Dec 2025 | Direct |
| Brian Kenneth Roberts | RZLT | Common Shares | Purchase | 9.99% | $47,600 | $1.70 | 28,000 | 308,352 | 16 Dec 2025 | Direct |
| Daron Evans | RZLT | Common Shares | Purchase | 55.6% | $4,475 | $1.79 | 2,500 | 7,000 | 15 Dec 2025 | Held by minor child #3 |
| Daron Evans | RZLT | Common Shares | Purchase | 55.6% | $4,462 | $1.78 | 2,500 | 7,000 | 15 Dec 2025 | Held by minor child #2 |
| Daron Evans | RZLT | Common Shares | Purchase | 10.6% | $70,640 | $1.77 | 40,000 | 415,900 | 15 Dec 2025 | Direct |
| Nevan C. Elam | RZLT | Common Shares | Purchase | 5.25% | $50,880 | $1.59 | 32,000 | 641,119 | 15 Dec 2025 | Direct |
| Sunil Patilal Karnawat | RZLT | Common Shares | Purchase | 20.4% | $19,599 | $1.62 | 12,100 | 71,542 | 15 Dec 2025 | Direct |
| Daron Evans | RZLT | Common Shares | Purchase | 8.69% | $53,167 | $5.04 | 10,549 | 131,900 | 09 Dec 2025 | Direct |
| Brian Kenneth Roberts | RZLT | Common Shares | Award | 78.2% | 123,000 | 280,352 | 19 Nov 2025 | Direct | ||
| Brian Kenneth Roberts | RZLT | Employee Stock Option (Right to Buy) | 72,000 | 72,000 | 19 Nov 2025 | Direct | ||||
| Sunil Patilal Karnawat | RZLT | Common Shares | Award | 116.6% | 32,000 | 59,442 | 19 Nov 2025 | Direct | ||
| Sunil Patilal Karnawat | RZLT | Employee Stock Option (Right to Buy) | Award | 19,000 | 19,000 | 19 Nov 2025 | Direct | |||
| Nevan C. Elam | RZLT | Common Shares | Award | 108.5% | 317,000 | 609,119 | 19 Nov 2025 | Direct | ||
| Nevan C. Elam | RZLT | Employee Stock Option (Right to Buy) | Award | 186,000 | 186,000 | 19 Nov 2025 | Direct | |||
| Daron Evans | RZLT | Common Shares | Award | 39.8% | 107,000 | 375,900 | 19 Nov 2025 | Direct | ||
| Daron Evans | RZLT | Employee Stock Option (Right to Buy) | Award | 63,000 | 63,000 | 19 Nov 2025 | Direct | |||
| Nerissa Kreher | RZLT | Common Shares | Award | 55.9% | 21,000 | 58,576 | 19 Nov 2025 | Direct | ||
| Nerissa Kreher | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Wladimir Hogenhuis | RZLT | Common Shares | Award | 22.6% | 21,000 | 114,025 | 19 Nov 2025 | Direct | ||
| Wladimir Hogenhuis | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Erik Harris | RZLT | Common Shares | Award | 21,000 | 21,000 | 19 Nov 2025 | Direct | |||
| Erik Harris | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Young-Jin Kim | RZLT | Common Shares | Award | 14% | 21,000 | 170,950 | 19 Nov 2025 | Direct | ||
| Young-Jin Kim | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Philippe Fauchet | RZLT | Common Shares | Award | 60.9% | 21,000 | 55,500 | 19 Nov 2025 | Direct | ||
| Philippe Fauchet | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Gil M. Labrucherie | RZLT | Common Shares | Award | 60.9% | 21,000 | 55,500 | 19 Nov 2025 | Direct | ||
| Gil M. Labrucherie | RZLT | Director Stock Option (Right to Buy) | Award | 12,000 | 12,000 | 19 Nov 2025 | Direct | |||
| Sunil Patilal Karnawat | RZLT | Common Shares | Award | 1023.8% | 25,000 | 27,442 | 18 Aug 2025 | Direct | ||
| Sunil Patilal Karnawat | RZLT | Employee Stock Option (Right to Buy) | Award | 275,000 | 275,000 | 18 Aug 2025 | Direct | |||
| Brian Kenneth Roberts | RZLT | Common Shares | Purchase | 19.2% | $10,939 | $4.38 | 2,500 | 15,500 | 25 Jun 2025 | Direct |
| Daron Evans | RZLT | Common Shares | Purchase | 1.89% | $20,250 | $4.05 | 5,000 | 268,900 | 24 Jun 2025 | Direct |
| Young-Jin Kim | RZLT | Common Shares | Purchase | 17.1% | $3,999,999 | $3.25 | 1,230,769 | 8,423,386 | 13 Jun 2025 | Held by Handok, Inc. |
| Nerissa Kreher | RZLT | Common Shares | Purchase | 8.92% | $9,997 | $3.25 | 3,076 | 37,576 | 13 Jun 2025 | Direct |
| Nerissa Kreher | RZLT | Common Shares | Award | 35.3% | 9,000 | 34,500 | 10 Jun 2025 | Direct | ||
| Nerissa Kreher | RZLT | Director Stock Options (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct | |||
| Gil M. Labrucherie | RZLT | Common Shares | Award | 35.3% | 9,000 | 34,500 | 10 Jun 2025 | Direct | ||
| Gil M. Labrucherie | RZLT | Director Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct | |||
| Wladimir Hogenhuis | RZLT | Common Shares | Award | 10.7% | 9,000 | 93,025 | 10 Jun 2025 | Direct | ||
| Wladimir Hogenhuis | RZLT | Director Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct | |||
| Young-Jin Kim | RZLT | Common Shares | Award | 6.39% | 9,000 | 149,950 | 10 Jun 2025 | Direct | ||
| Young-Jin Kim | RZLT | Director Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct | |||
| Daron Evans | RZLT | Common Shares | Award | 10.9% | 26,000 | 263,900 | 10 Jun 2025 | Direct | ||
| Daron Evans | RZLT | Employee Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 10 Jun 2025 | Direct | |||
| Philippe Fauchet | RZLT | Common Shares | Award | 35.3% | 9,000 | 34,500 | 10 Jun 2025 | Direct | ||
| Philippe Fauchet | RZLT | Director Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 10 Jun 2025 | Direct |
* marks a reported price that did not pass the local price check.